News
An Essential Report on Diagnostic Imaging Agents - Discover the Next Generation of New Contrast Agents to Detect Metabolic Changes at the Molecular Level
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets (http://www.researchandmarkets.com/research/735b4b/diagnostic_imaging) has announced the addition of the "Diagnostic Imaging Agents - The Next Generation" report to their offering.
Driven by advances in molecular probe design and biomarker detection methodologies, new imaging agents that can improve visualization of pathologies and cellular processes are changing the practice of diagnostic medicine. The ability of this new generation of contrast agents to detect metabolic changes at the molecular level has significant potential for improving visualization and quality of care. Targetable and activatable imaging agents are gaining interest for a wide range of diagnostic applications that include cardiology, neurology and soft tissue tumor detection. The number of healthcare conditions that can be effectively imaged noninvasivelyis expanding as a result of these innovative detection technologies. Targeted and activatable imaging agents offer a unique capability to generate unambiguous images by exploiting specific molecular targets, pathways or cellular processes. This new wave of imaging agents signals a paradigm shift in which the reagents take on new importance alongside system hardware in revenue projections and product line ROI.
Imaging Processes at the Molecular and Cellular Level:
A number of challenging opportunities are on the horizon for medical imaging. Unlike many other sectors of the healthcare industry where technology successes periodical occur that seem to propel the market forward, these opportunities are being driven by the migratory advances of academic, public (government) and commercial research programs.
The potential for the next generation of diagnostic imaging agents is significant. SPECT and PET tracers have been developed to measure oxidative metabolism, fatty acid and amino acid metabolism, and pre- and post-synaptic receptor densities. The ability of these first-generation agents to improve diagnostic and treatment capabilities is now driving a directed effort to develop the next-generation of molecular agents. To sense biological processes such as gene expression, angiogenesis, apoptosis or cell trafficking in vivo, imaging reporter agents that interact specifically with molecular targets and appropriate imaging systems are currently under development.
Molecular imaging will greatly reduce the need for animal tissue sampling or human biopsy when studying the progression of a disease or the follow-up of a gene therapy. It has the advantage of being non-invasive, and because it can be repeated many times, it provides both spatial and temporal dimensions to the understanding of the gene expression of the disease or therapy.
Market Data
The study presents qualitative and quantitative data and information on key market measures and benchmarks: - Imaging Segment Assessment - Commercial Limitations - Global Market Analysis - Company Profiles - Technology Assessments - Alliances and Strategies - Commercialization Strategies - Regulatory Factors - Imaging Agent Development Criteria - Technology Risk Factors
Key Topics Covered: - Advanced Imaging Agents - Market Dynamics - Diagnostic Imaging Technology - Imaging Modalities & the Potential of Molecular Imaging - The Need for New Imaging Agents - Clinical Applications -Near-Term Assessment and Future Impact - Market Factors - Company Profiles
For more information visit http://www.researchandmarkets.com/research/735b4b/diagnostic_imaging
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
